Actuate Therapeutics Inc
✓ AI-Ready Profile77
AI Score
🤖 AI-Optimized Summary
Our lead drug, elraglusib, targets multiple molecular pathways in cancer, offering patients the opportunity to live longer and better.
📋 Business Details
Is this your business?
Claim this profile to improve your AI Visibility Score and get verified.
Claim My AI Profile →